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Abstract
Background: Mis-implementation (i.e., the premature termination or inappropriate continuation of public health
programs) contributes to the misallocation of limited public health resources and the sub-optimal response to the
growing global burden of chronic disease. This study seeks to describe the occurrence of mis-implementation in
four countries of differing sizes, wealth, and experience with evidence-based chronic disease prevention (EBCDP).
Methods: A cross-sectional study of 400 local public health practitioners in Australia, Brazil, China, and the United
States was conducted from November 2015 to April 2016. Online survey questions focused on how often mis-
termination and mis-continuation occur and the most common reasons programs end and continue.
Results: We found significant differences in knowledge of EBCDP across countries with upwards of 75% of
participants from Australia (n = 91/121) and the United States (n = 83/101) reporting being moderately to extremely
knowledgeable compared with roughly 60% (n = 47/76) from Brazil and 20% (n = 21/102) from China (p < 0.05). Far
greater proportions of participants from China thought effective programs were never mis-terminated (12.2% (n =
12/102) vs. 1% (n = 2/121) in Australia, 2.6% (n = 2/76) in Brazil, and 1.0% (n = 1/101) in the United States; p < 0.05)
or were unable to estimate how frequently this happened (45.9% (n = 47/102) vs. 7.1% (n = 7/101) in the United
States, 10.5% (n = 8/76) in Brazil, and 1.7% (n = 2/121) in Australia; p < 0.05). The plurality of participants from
Australia (58.0%, n = 70/121) and the United States (36.8%, n = 37/101) reported that programs often mis-continued
whereas most participants from Brazil (60.5%, n = 46/76) and one third (n = 37/102) of participants from China
believed this happened only sometimes (p < 0.05). The availability of funding and support from political authorities,
agency leadership, and the general public were common reasons programs continued and ended across all
countries. A program’s effectiveness or evidence-base—or lack thereof—were rarely reasons for program
continuation and termination.
Conclusions: Decisions about continuing or ending a program were often seen as a function of program
popularity and funding availability as opposed to effectiveness. Policies and practices pertaining to programmatic
decision-making should be improved in light of these findings. Future studies are needed to understand and
minimize the individual, organizational, and political-level drivers of mis-implementation.
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Background
Chronic diseases like diabetes, cancer, and heart disease
are the largest causes of morbidity and mortality world-
wide [1, 2]. The field of evidence-based public health,
[3–6] namely evidence-based chronic disease prevention
(EBCDP) seeks to address the challenge of chronic dis-
ease prevention by using the best available scientific evi-
dence, applying program-planning frameworks, engaging
the community in decision making, using data and infor-
mation systems systematically, conducting sound evalu-
ation, and disseminating what is learned [7, 8]. An
evidence-based approach to prevention and control can
significantly prevent and minimize chronic disease bur-
den [9–11].
However, despite its enhanced ability to address
chronic disease, EBCDP is not as widely used as it
should be [7, 8, 12]. A considerable amount of the
breakdown in the pipeline between evidence production
and its application by public health practitioners takes
place at the state and local public health levels, which, in
the United States and other countries, have substantial
authority over protecting the public’s health [13]. Studies
have identified barriers impeding evidence-based public
health practice at the individual (e.g., lack of EBCDP
knowledge), agency/organizational (e.g., absence of lead-
ership support for EBCDP), community (e.g., absence of
critical community-based partnerships), sociocultural
(e.g., lack of societal demand for evidence-based pro-
grams), and political (e.g., lack of buy-in from policy-
makers) levels in the United States as well as in other
developed and developing countries [14–17].
Mis-implementation is defined as the state in which
effective interventions are prematurely ended (mis-ter-
mination) or, alternatively, ineffective interventions remain
in place (mis-continuation). While some literature has
examined overuse of clinical interventions in a medical
setting, [18–21] few studies have examined mis-imple-
mentation in public health [22]. Mis-implementation is
likely an important factor in understanding the lag in
EBCDP, as it points to the misallocation of resources, and
inadequate funding is a commonly-cited barrier to EBCDP
[23–25]. Mis-implementation may also be evidence of a
culture that does not value or prioritize evidence when
making programmatic decisions [26].
This study examined the perceived occurrence of
EBCDP program mis-implementation and the most
common reasons for program termination and continu-
ation in four countries: Australia, Brazil, China, and the
United States. These countries were selected because
they represent an array of structures and systems of pub-
lic health, which make them rich sources of insight into
mis-implementation around the world. They also
account for a large portion of the world’s chronic disease
burden and population [27]. Lastly, the four countries
are likely to represent different degrees of experience
with EBCDP, based on the greater volume of empirical
literature on the topic produced in Australia and the
United States relative to Brazil and China [28–37]. We
used a quantitative approach in the vein of O’Loughlin
et al. [38], who used a survey design to extend the in-
sights of generally case study of multiple case study
-based approaches to investigating health promotion
program sustainability.
Methods
Survey Development A 22-question, cross-sectional sur-
vey was developed based on a literature review of exist-
ing measures in EBCDP, [23, 39–41], a guiding frame
work based on previous work of the research team, [16,
41] as well as information gathered from 50 qualitative
interviews of local public health practitioners across the
four countries [24, 42]. The resulting instrument con-
tained questions across seven domains derived from pre-
vious research on disseminating evidence-based inter
ventions such as awareness of evidence-based public
health, adoption of approaches for learning about
evidence-based interventions, barriers to and facilitators
of implementing evidence-based interventions, and
mis-implementation (Additional file 1: Table S1). Where
possible (e,g, the domains of awareness of EBCDP inter-
ventions and barriers and facilitators of EBCDP imple-
mentation), questions were adapted from existing
literature. The mis-implementation questions consisted
of four of the 22 questions and were novel operationali-
zations of the mis-termination and mis-continuation
constructs, including the frequency of each and reasons
for each. New operationalizations were deemed neces-
sary due to the absence of existing options that interro-
gated the constructs of mis-termination and
mis-implementation in a few questions as well as the ab-
sence of a gold standard by which to validate concepts
of mis-implementation. Instruments examining facets of
mis-implementation such as sustainability and
de-adoption, which have traditionally been studied in
isolation, tend to be longer than was deemed advisable
for our instrument, which contained several other do-
mains in addition to mis-implementation [43–47]. For
example, the validated Program Sustainability Assess-
ment Tool is 40 items long spread across eight sus-
tainability domains [44]. The response options for the
two reason questions were derived from the qualita-
tive interviews as well as literature on common rea-
sons programs are terminated and sustained.
Prior to deployment, 13 chronic disease prevention
researchers including one male co-investigator, one
female coordinator, and three graduate student research
assistants from the United States; two female co-investi-
gators and one female research assistant from Australia;
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one male co-investigator and one male research assistant
from Brazil; and two male and one female
co-investigator along with one female research assistant
from China reviewed the survey. All of the authors were
included among the reviewers. The survey was also for-
ward- and backward-translated to Mandarin and Portu-
guese from English by members of the research team
and pilot tested in each country to ensure contextual ap-
propriateness. As a result, seven response items were
found to be inapplicable to participants from China and
were excluded from that version of the survey, but in-
cluded in the versions used in Australia, Brazil, and the
United States.
Study sample
Between November 2015 and April 2016, investigators in
each country recruited convenience samples of chronic
disease prevention practitioners working primarily at the
local and regional levels. Sampling was largely carried out
through national databases of chronic disease practi-
tioners, which helped ensure that the geographic diversity
of the invited participants reflected the distribution of
public health infrastructure in each country. Response
rates differed considerably across countries with 18% (n =
121/672) of those emailed completing the survey in
Australia, 46% (n = 76/165) in Brazil, 58% (n = 101/174) in
the United States, and 87% (n = 102/117) in China. Inves-
tigators deployed the survey to practitioners through a
link embedded in an email. All practitioners provided
informed consent. Practitioners in Australia and the
United States had the option of accepting a $20 USD gift
card for completing the survey. Investigators deemed such
financial incentives to be culturally inappropriate in Brazil
and China. The ethics review boards of The University of
Melbourne, Pontifica Universidade Catolica do Parana,
The Hong Kong Polytechnic University, and Washington
University in St. Louis approved this study.
Measures
Participants were first asked a series of sociodemographic
and employment history questions (e.g., age category, gen-
der, tenure with their organization, educational creden-
tials). They were then asked to rate their knowledge of
EBCDP on a 5-point Likert scale. Two questions opera-
tionalized mis-implementation in both its forms (i.e.,
mis-termination and mis-continuation). These questions
asked how often mis-termination and mis-continuation
occurred with response options “never,” “sometimes,”
“often,” “I do not know,” and “not applicable”. Two more
questions then asked for the three most common reasons
programs ended and continued with roughly a dozen dif-
ferent response options for each as well as an open-ended
“other” option.
Statistical analysis
To assess bivariate differences in our key outcomes of
interest, how often mis-termination and mis-continua
tion occurred and the reasons for program continuation
and termination by country, as well as individual and
agency characteristics by country, we used chi-square
tests and Fisher’s Exact tests. Fisher’s Exact test was used
for contingency tables with expected cell counts of fewer
than five. All analyses were conducted using SPSS ver-
sion 23. Missing data was minimal and excluded from
analyses.
Results
Sample characteristics by country (Table 1)
The distribution of respondents differed significantly
across countries by gender, age, and education (Table 1).
Brazil was more evenly split among female and male
participants (65.8%, n = 50/76) compared with Australia
(88.4%, n = 107/121), China (71.7%, n = 71/102), and the
United States (87.1%, n = 88/101), whose participants
skewed female. Practitioners from Australia, the United
States, and Brazil were concentrated and fairly evenly
distributed between the ages of 30 and 59. Practitioners
from China tended to be younger. Practitioners from
Australia and the United States more commonly had ad-
vanced graduate degrees. The survey may have been in-
adequately customized to the educational credentials in
Brazil due to the high rate of “other” responses. Most of
those who endorsed this option reported working in a
public health specialist role. Positions varied widely by
country reflecting the diversity of ways in which each
country staff public health.
Evidence-based knowledge and Mis-implementation
frequency by country (Table 2)
We found significant differences in knowledge of
EBCDP across countries with upwards of 75% of partici-
pants from Australia (n = 91/121) and the United States
(n = 83/101) reporting being moderately to extremely
knowledgeable compared with roughly 60% (n = 47/76)
from Brazil and 20% (n = 21/102) from China (Table 2).
Significant differences in perceptions of mis-termination
and mis-continuation frequency also existed. Far greater
proportions of participants from China thought effective
programs were never mis-terminated (12.2% (n = 12/
102) vs. 1% (n = 2/121) in Australia, 2.6% (n = 2/76) in
Brazil, and 1.0% (n = 1/101) in the United States) or were
unable to estimate how frequently this happened (45.9%
(n = 47/102) vs. 7.1% (n = 7/101) in the United States,
10.5% (n = 8/76) in Brazil, and 1.7% (n = 2/121) in
Australia).. The majority of participants from Australia
(56.4%, n = 68/121) thought mis-termination occurred
often, compared to 36.8% (n = 28/76) in Brazil and 40.4%
(n = 41/101) in the United States. Participants from all
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Table 1 Differences in Participant and Agency Characteristics by Country
Australia Brazil China United States Chi-Sq p-value
N = 121 N = 76 N = 102 N = 101
Characteristic % n % n % n % n
Participant Demographics
Female 88.4% 107 65.8% 50 71.7% 71 87.1% 88 32.9 < 0.0001
Age 89.0 < 0.0001
21–29 20.7% 25 8.2% 6 21.6% 22 6.9% 7
30–39 33.1% 40 38.4% 28 56.9% 58 21,8% 22
40–49 14.9% 18 31.5% 23 10.8% 11 28.7% 29
50–59 20.7% 25 21.1% 16 3.9% 4 28.7% 29
60+ 10.7% 13 3.9% 3 0.0% 0 10.9% 11
Missing 0.0% 0 0.0% 0 6.7% 7 3.0% 3
Education/Credentials 92.5 < 0.0001
Doctorate 14.2% 17 4.0% 3 0.0% 0 6.9% 7
Master’s 42.5% 51 32.0% 24 23.5% 24 48.5% 49
Bachelor’s 30.0% 36 22.7% 17 68.6% 70 27.8% 28
Other 13.3% 16 41.3% 31 7.8% 8 15.8% 16
Missing 0.8% 1 1.3% 1 0.0% 0 1.0% 1
Primary Position
Physician 37.2% 45 1.3% 1 2.9% 3 41.6% 42 77.4 < 0.0001
Community Health Nurse 3.3% 4 13.2% 10 43.1% 44 7.9% 8 73.8 < 0.0001
Department Head 5.0% 6 28.9% 22 5.9% 6 14.9% 15 30.2 < 0.0001
Nutritionist 0.8% 1 9.2% 7 40.2% 41 0.0% 0 103.5 < 0.0001
Statistician 15.7% 19 26.3% 20 3.9% 4 1.0% 1 36.5 < 0.0001
Health Educator 13.2% 16 2.6% 2 2.0% 2 18.8% 19 22.5 < 0.0001
Division of Bureau Head/Deputy Director 0.0% 0 11.8% 9 0.0% 0 10.9% 11 26.6 < 0.0001
Program Manager/Administrator/Coordinator 9.1% 11 1.3% 1 0.0% 0 0.0% 0 22.4 < 0.0001
Academic Research 9.1% 11 0.0% 0 0.0% 0 0.0% 0 26.1 < 0.0001
Other 1.6% 2 5.2% 4 2.0% 2 2.1% 3 6.9 < 0.0001
Missing 5.0% 6 0.0% 0 0.0% 0 2.0% 2 4.2 < 0.0001
Agency Features
Number of Employees 83.8 < 0.0001
0–100 37.7% 43 38.0% 27 9.8% 10 56.4% 57
101–400 20.2% 23 28.2% 20 64.7% 66 24.8% 25
> 400 42.1% 48 33.8% 24 21.6% 22 17.8% 18
Missing 5.8% 7 6.7% 5 3.9% 4 1.0% 1
Size of Population Served 127.0 < 0.0001
0–49,999 28.3% 30 29.4% 20 0.0% 0 23.8% 24
50,000-99,999 10.4% 11 10.3% 7 0.0% 0 24.8% 25
100,000-399,999 20.8% 22 27.9% 19 81.4% 83 25.8% 26
> 400,000 40.6% 43 32.4% 22 18.6% 19 23.8% 24
Missing 12.3% 15 10.5% 8 0.0% 0 2.0% 2
Boldface indicates significant at alpha < 0.05
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Table 2 Differences in Knowledge of EBCDP, Mis-implementation, and Reasons Programs End and Continue by Country
Australia Brazil China United States
N = 121 N = 76 N = 102 N = 101 Chi-Sq p-value
Characteristic % n % n % n % n
Knowledgeable of EBCDP 146.7 < 0.0001
Not at all 0.8% 1 2.6% 2 15.7% 16 1.0% 1
Slightly 4.2% 5 2.6% 2 31.4% 32 2.0% 2
Somewhat 20.2% 24 32.9% 25 32.4% 33 14.9% 15
Moderately 60.0% 73 44.7% 34 18.6% 19 54.5% 55
Extremely 15.0% 18 17.1% 13 2.0% 2 27.7% 28
Mis-implementation
Frequency of Mis-Termination (Inappropriate Ending) 148.4 < 0.0001
Never 1.7% 2 2.6% 2 12.2% 12 1.0% 1
Sometimes 31.6% 38 39.5% 30 36.7% 37 51.5% 52
Often 56.4% 68 36.8% 28 5.1% 5 40.4% 41
Don’t Know 9.4% 11 10.5% 8 45.9% 47 7.1% 7
Missing 1.7% 2 10.5% 8 1.0% 1 0% 0
Frequency of Mis-Continuation (Inappropriate Continuation) 241.1 < 0.0001
Never 1.7% 2 10.5% 8 11.0% 11 5.9% 6
Sometimes 0.0% 0 60.5% 46 33.0% 34 19.8% 20
Often 58.0% 70 7.9% 6 4.0% 4 36.8% 37
Don’t Know 37.8% 46 14.5% 11 52.0% 53 34.5% 35
Missing 2.5% 3 6.6% 5 0% 0 3.0% 3
Reasons Programs End and Continue
Reasons Programs End (% of times in top 3)a
Grant funding ended 63.6% 77 43.4% 33 24.5% 25 84.2% 85 80.8 < 0.0001
Funding diverted to a higher priority program 31.4% 38 31.6% 24 20.6% 21 36.6% 37 6.6 0.085
Change in political leadership 50.4% 61 47.4% 36 8.8% 9 11.9% 12 73.2 < 0.0001
Program was evaluated but did not demonstrate impact 22.3% 27 21.1% 16 42.2% 43 9.9% 10 30.0 < 0.0001
Opposition/lack of support from policy makers 26.4% 32 28.9% 22 18.6% 19 18.8% 19 4.4 0.219
Program was challenging to maintain 9.9% 12 10.5% 8 48.0% 49 20.8% 21 55.6 < 0.0001
Program was never evaluated 19.0% 23 23.7% 18 10.8% 11 15.8% 16 5.6 0.130
Opposition/lack of support from the general public 2.5% 3 21.1% 16 38.2% 39 8.9% 9 56.9 < 0.0001
Opposition/lack of support from leaders in my agency 10.7% 13 35.5% 27 13.7% 14 10.9% 11 26.1 < 0.0001
A program champion departed 22.3% 27 25.0% 19 5.9% 6 9.9% 10 19.1 < 0.0001
Program was expensive 5.8% 7 11.8% 9 15.7% 16 8.9% 9 6.3 0.098
Program was not evidence-based 3.3% 4 23.7% 18 12.7% 13 3.0% 3 29.4 < 0.0001
Program was adopted or continued by other organizations 4.1% 5 2.6% 2 2.0% 2 13.9% 14 16.9 0.001
Insurance funding/coverage ended 1.7% 2 9.2% 7 0.0% 0 7.9% 8 14.5 0.002
Reasons Programs Continue (% of times in top 3)a
Sustained support from policymakers 27.3% 33 43.4% 33 31.4% 32 22.1% 22 11.6 0.009
Sustained funding 28.1% 34 39.5% 30 36.3% 37 35.6% 36 3.2 0.358
Sustained support from leaders in your agency 27.3% 33 18.4% 14 35.3% 36 24.8% 25 6.7 0.084
Absence of alternative options 28.1% 34 26.3% 20 22.5% 23 17.8% 18 3.6 0.310
Program was never evaluated 33.1% 40 35.5% 27 8.8% 9 16.8% 17 27.1 < 0.0001
Sustained support from the general public 15.7% 19 21.1% 16 37.3% 38 15.8% 16 18.7 < 0.0001
Furtado et al. BMC Public Health          (2019) 19:270 Page 5 of 10
countries found it more challenging to estimate how fre-
quently programs were mis-continued, with 37.8% (n =
46/121) in Australia, 14.5% in Brazil (n = 11/76), 52.0%
(n = 53/102) in China, and 34.5% (n = 35/101) in the
United States reporting they did not know. The plurality
of participants from Australia (58.0%, n = 70/121) and
the United States (36.8%, n = 37/101) reported that pro-
grams often mis-continued whereas most participants
from Brazil (60.5%, n = 46/76) and one third (n = 37/102)
of participants from China believed this happened only
sometimes.
Reasons programs end and continue by country
To provide context to our examination of mis-imple
mentation, we asked participants to select from a list (or
suggest an alternative) the three most common reasons
why programs ended and continued (Table 2). We docu-
mented a handful of nearly “universal” (i.e., commonly-
cited across all countries) reasons for program termin-
ation including funding ending or being diverted and a
lack of support from key stakeholders. In addition to
these reasons, practitioners from Australia and Brazil
reported that changes in political leadership often led to
program termination (50.4%, n = 61/121 and 47.4%, n =
36/76 respectively). Among participants from Brazil, lack
of support from agency leadership was also one of the
most frequently cited reasons for programs ending
(35.5%, n = 27/76). China’s top reasons differed signifi-
cantly from the other countries’ and included that pro-
grams were difficult to maintain (48.0%, n = 49/102),
programs were not demonstrating impact (42.2%, n =
43/102), and lack of support from the public (38.2%, n =
39/102). In the United States the prevailing issue was by
far funding ending (84.2%, n = 85/101) or being diverted
(36.6%, n = 37/101).
We observed less within-country consensus on why
programs continued, as indicated by the fact that no sin-
gle reason was endorsed by the majority of participants
in any country. However, some of the same reasons did
rise to the top across countries including sustained fund-
ing, the absence of alternative options, sustained support
from agency leadership, and programs that were easy to
maintain. Sustained support from policymakers seemed
to be particularly influential for keeping programs run-
ning in Brazil, with 43.4% (n = 33/76) of participants cit-
ing this reason. Sustained support from the general
public was a top reason for continuing programs in
China (37.3%, n = 38/102) but not in Australia (15.7%, n
= 19/121), Brazil (21.1%, n = 16/76), or the United States
(15.8%, n = 16/101).
Discussion
Mis-implementation is an under-studied barrier to
evidence-based practice. While de-adoption is being
studied in the clinical space, where it goes by some four
dozen names, [20, 21] less attention has been paid to it
in the public health arena. In the field of public health,
sustainability, or the continuation or discontinuation of
a program or intervention once implemented and after
the initial funding has ended, [48, 49] aligns to one half
of mis-implementation. The dual nature of mis-imple
mentation seems to be unexplored even in the domain
of evidence-based medicine, where the focus is on dis-
investment in low-value clinical practices [18–21].
We assert that mis-implementation is a two-sided
practice that refers both to the de-adoption of effective
programs, policies, or interventions (i.e., “mis-termina-
tion”) and to the continuation of ineffective programs,
policies, or interventions that should end (i.e., “mis-con-
tinuation”). This exploratory study is likely the first to
examine mis-implementation in both of its forms in an
applied public health setting in multiple countries.
Our results suggest that mis-implementation occurs
quite often and that mis-termination is more common—
or more visible—than mis-continuation. Over 70% of
practitioners surveyed in Australia, Brazil, and the
United States reported that mis-termination happened
sometimes or often. Among American practitioners,
40% (n = 40/101) thought mis-termination occurred
often and 36.8% (n = 37/100) thought mis-continuation
happened often. These findings generally support the
only other published study to the authors’ knowledge
Table 2 Differences in Knowledge of EBCDP, Mis-implementation, and Reasons Programs End and Continue by Country (Continued)
Australia Brazil China United States
N = 121 N = 76 N = 102 N = 101 Chi-Sq p-value
Characteristic % n % n % n % n
Program was easy to maintain 24.0% 29 18.4% 14 21.6% 22 23.8% 24 1.0 0.799
Presence of a program champion 23.1% 28 28.9% 22 13.7% 14 21.8% 22 6.3 0.096
Program was low-cost 19.0% 23 18.4% 14 8.8% 9 18.8% 19 5.6 0.135
Prohibitive costs of starting something new 13.2% 16 9.2% 7 9.8% 10 6.9% 7 2.5 0.473
Program was considered evidence-based 10.7% 13 3.9% 3 16.7% 17 6.9% 7 9.3 0.026
Boldface indicates significant at alpha < 0.05
aThe original series of questions asked participants to select the three most frequent reasons from the lists above
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that has examined mis-implementation in public health
[22]. This cross-sectional study of over 900 public health
practitioners at state and local public health departments
found similar rates of mis-termination and mis-con
tinuation with reasons for each differing somewhat at
the state versus local level.
Interestingly, mis-continuation seemed to happen less
often across all countries, with 37–68% of participants
(n = 70/121 in Australia, n = 52/76 in Brazil, n = 34/102
in China, and n = 57/101 in the United States) reporting
that it happened often or sometimes. This could point to
a particular struggle with sustainment in the delivery of
public health at the local level [50, 51]. However, the dif-
ference could also reflect a greater difficulty identifying
mis-continuation relative to mis-termination. Indeed, a
greater portion of practitioners across all countries did
not know how often mis-continuation occurred com-
pared to mis-termination. Mis-termination involves
recalling instances when things came to an end, which is
likely inherently more memorable than that the absence
of such an ending (i.e., mis-continuation). This potential
recall bias should be considered as research in the area
of mis-implementation progresses and measures are
optimized.
Practitioners from China were both more optimistic and
more uncertain about the occurrence of mis-implementa-
tion relative to their colleagues in other countries. A
greater proportion of them than in any other country
thought mis-termination and mis-continuation never hap-
pened. However, the plurality of Chinese participants were
unable to gauge how often either type of mis-implementa-
tion occurred. The top-down culture in China’s public
health system may make observing mis-implementation
more difficult. The participants from China predominantly
worked for government-run hospitals. Because of the cen-
tralized health planning model used in China, wherein the
central government has overall responsibility for national
health policy and administration, local practitioners may
be less involved in determining whether and why pro-
grams continue or end. Officials working in such an envir-
onment might not know how often mis-implementation
occurs or might assume that programs are continuing or
ending for good reasons (i.e., that mis-implementation
does not occur often).
It is also worth noting that practitioners from China
self-reported significantly lower knowledge of EBCDP,
and that lack of knowledge might impede their ability to
identify mis-continuation and mis-termination. The
lower ratings may also reflect cultural differences in will-
ingness to claim expertise in something. In Australia and
the United States, where the large majority of partici-
pants tended to rate their knowledge to be moderate or
excellent, mis-implementation was perceived as occur-
ring far more often. This aligns with literature reporting
that a country’s development status can predict struc-
tural differences in the provision of public health mea-
sures and clinical healthcare that influence their
program implementation outcomes and their awareness
of evidence-based practices [52–54]. Further research
should investigate whether the positive correlation be-
tween knowledge and perceived rate of mis-implementa-
tion persists at the individual level and when controlling
for other factors.
Consideration of the reasons participants gave for pro-
grams continuing and ending brings the phenomenon of
mis-implementation into greater focus. “Grant funding
ending” was the most commonly-cited reason for pro-
grams ending in Australia and the United States and the
second most-common reason in Brazil. This reflects the
growing concern around sustainment, or the continu-
ation of a program once implemented and generally after
initial funding from federal or state agencies has been
exhausted [17]. In addition to funding, changes in polit-
ical leadership and changes in priorities (which are often
dictated by political authorities) were also common rea-
sons programs end that align with the literature base
[19, 22]. Reviews of the phenomenon of sustainment
similarly find that organizational capacity, in addition to
context, processes, and other factors influence whether a
program is maintained [48, 55]. Scheirer [49] discusses
three categories of factors that affect sustainability be-
yond securing new funding including aspects of project
design and characteristics (e.g., whether the program is
modifiable to meet local need), factors within the
organizational setting (e.g., the presence of a program
champion), and factors in the broader community envir-
onment (e.g., support from external community leaders.
As found by Scheirer and confirmed by this study, staff
tend to focus on challenges securing replacement fund-
ing as the primary obstacle to sustainment, potentially at
the exclusion of some of these other factors.
Just as interesting as the most commonly cited rea-
sons for program termination are the least commonly
cited reasons. In both Australia and the United States,
not being evidence-based was rarely the reason a pro-
gram ended, which underscores the phenomenon of
mis-continuation. Similarly, in Brazil and China, pro-
grams infrequently ended because they were picked
up by other organizations, a viable approach to sus-
tainment. Perhaps the most legitimate reason for a
program to end is because it was evaluated and did
not demonstrate impact. Less than a quarter of prac-
titioners in Australia, Brazil, and the United States
cited this as a top-three reason, suggesting that pro-
grams that end due to lack of funding, or lack of
support, or any of the other most common reasons,
are often terminated without a clear sense of whether
they are effective.
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Practitioners from all countries agreed that having sus-
tained support from various key stakeholders (e.g., pol-
icymakers, agency leadership) was among the top
reasons programs continued. Several practitioners from
Australia and the United States used the open-ended re-
sponse option to point to practitioner preferences and
attachment to programs leading to the continuation of
those programs. Sustained funding, the absence of alter-
natives, and ease of maintenance also led to the continu-
ation of programs. Again, not being evidence-based or
evaluated for effectiveness were amongst the least com-
mon reasons programs ended across all four countries.
While there was consistency in reasons programs end,
the cross-country differences point to important con-
textual differences in the culture and structure sur-
rounding public health that are important to keep in
mind and further explore when seeking to enhance
evidence-based public health around the world. In
Brazil, for example, policymakers seem to be particularly
influential at determining whether programs end and
continue. There, a shift in political leadership was the
top reason programs end and sustained support from
policymakers was the most common reason programs
continued. The support of agency leadership and pro-
gram champions was also key. Practitioners from China
reported that the support of the public was critical to
keeping programs in place. In both Brazil and China,
EBCDP seems to be in a more nascent stage than in
Australia and the United States, as reflected by the
greater degrees to which Brazil and China rely upon
support from various stakeholder groups compared to
the more autonomous systems in Australia and the
United States and lower levels of self-attested knowledge
of EBCDP. These differences in influences will be im-
portant to acknowledge when crafting strategies to im-
prove evidence-based implementation in different
countries.
Despite the cross-country differences, however, the
prevailing theme from this study is that, across all coun-
tries, decisions about ending and continuing programs
often seem to be made with incomplete consideration of
whether the program in question was evidence-based or
demonstrating impact. Instead decisions seem to be
made based on what can be funded, what has support
from key stakeholders, and how easy it is to maintain
the status quo relative to the challenge of starting some-
thing new. These findings have potential implications for
public health policy and practice. Decisions regarding
the continuation or termination of programs should be
at least partly a function of their impact and evidence
base in addition to other more political and logistical/ef-
ficiency factors. These decisions should also be made in
a transparent manner to ensure that staff have visibility
into how program commitments are made or withdrawn.
Such transparency may encourage greater adherence and
to decision-making protocols and accountability.
Limitations
The findings reported here are exploratory and should
be considered in light of the study’s limitations. We re-
lied on a small set of questions pertaining to perceptions
of mis-implementation, program termination and con-
tinuation, and knowledge of EBCDP that have not yet
been psychometrically tested or independently validated
against a gold standard. Selection bias is quite possible,
given the non-randomized nature of the study, the adap-
tations to sampling strategies to accommodate country-
specific differences, and the widely ranging response
rates. While the survey instrument was forward- and
backward-translated from English to Mandarin and Por-
tuguese to ensure fidelity, some concepts and responses
may have been lost in translation given the substantial
social, cultural, and structural differences between the
four countries. Self-reported perceptions of the fre-
quency of and reasons for mis-implementation are also
susceptible to recall bias. Additionally, perceptions of
mis-implementation may vary by a number of individual
and organizational factors, including tenure in position,
job responsibilities, programmatic area, and organiza-
tional structure, some of which this study examined, but
none of which were included in a multivariable model
predicting mis-implementation due to small cell sizes.
Conclusions
Mis-implementation by definition involves the
mis-allocation of scarce public health resources. This is
the first cross-national study with standardized methods
to examine patterns in mis-implementation. It found
that public health practitioners across four diverse coun-
tries perceive mis-implementation fairly regularly as they
seek to prevent chronic diseases at the local levels.
While the reasons programs end and continue inappro-
priately vary from country to country, they generally
support the common theme that the culture of public
health practice seems to be too often focused on what is
easy, familiar, and appealing to external stakeholders as
opposed to what is impactful, evidence-based, or chal-
lenging. Future studies are needed to examine in closer
detail the individual, organizational, and political-level
predictors of mis-implementation as well as approaches
to minimizing this mis-use of limited resources.
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